Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease

Dopaminergic progenitor cells that were derived from a patient’s induced pluripotent stem cells were implanted bilaterally in the putamen. Clinical and PET studies suggested survival of the cells and clinical stability over a period of 24 months, without dyskinesias.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2020-05, Vol.382 (20), p.1926-1932
Hauptverfasser: Schweitzer, Jeffrey S, Song, Bin, Herrington, Todd M, Park, Tae-Yoon, Lee, Nayeon, Ko, Sanghyeok, Jeon, Jeha, Cha, Young, Kim, Kyungsang, Li, Quanzheng, Henchcliffe, Claire, Kaplitt, Michael, Neff, Carolyn, Rapalino, Otto, Seo, Hyemyung, Lee, In-Hee, Kim, Jisun, Kim, Taewoo, Petsko, Gregory A, Ritz, Jerome, Cohen, Bruce M, Kong, Sek-Won, Leblanc, Pierre, Carter, Bob S, Kim, Kwang-Soo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Dopaminergic progenitor cells that were derived from a patient’s induced pluripotent stem cells were implanted bilaterally in the putamen. Clinical and PET studies suggested survival of the cells and clinical stability over a period of 24 months, without dyskinesias.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1915872